A Microgel that Induces Immune Acceptance of Implanted Islet Cells
July 26, 2022 | Terry Sharrer
Researchers at Massachusetts General Hospital and collaborators report “. . . a strategy through which cotransplantation of allogeneic islets and streptavidin (SA)–FasL–presenting microgels to the omentum under transient rapamycin monotherapy resulted in robust glycemic control, sustained C-peptide levels, and graft survival in diabetic nonhuman primates for >6 months. Surgical extraction of the graft resulted in prompt hyperglycemia.” MORE
Image Credit: Science.org